TerminatedPhase 4

A Study Evaluating the Safety of the Nasal Pump

Stopped: Internal strategy change. Not related to safety concerns.

United States5 participantsStarted 2024-02-21

Plain-language summary

The objective of this study is to determine the safety of the Tyrvaya nasal pump.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Be at least 18 years of age * Have provided verbal and written informed consent * Willing to comply with all study related visits and procedures Exclusion Criteria: * Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to Visit 1.

What they're measuring

Number of Participants With Adverse Events

Timeframe: 7 days

Trial details

NCT IDNCT06329687

SponsorOyster Point Pharma, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-02-28

Results submitted2025-03-24

View on ClinicalTrials.gov More Dry Eye trials